OPEN END TURBO BULL OPTIONSSCHEIN - ASTRAZENECA | Delayed Deutsche Boerse AG 11:39:41 29/05/2024 BST | ||
| 6.22 EUR | 0.00% |
|
| Current month | -0.64% | ||
| 1 month | -0.80% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ASTRAZENECA PLC
Latest news about ASTRAZENECA PLC
| Date | Price | Change |
|---|---|---|
| 29/05/24 | 6.22 | 0.00% |
| 28/05/24 | 6.22 | -5.18% |
| 27/05/24 | 6.56 | -0.46% |
| 24/05/24 | 6.59 | -1.05% |
| 23/05/24 | 6.66 | +1.22% |
Delayed Quote Deutsche Boerse AG
Last update May 29, 2024 at 11:39 am
More quotesStatic data
| Product type | Certificat Turbo |
|---|---|
| Buy / Sell | CALL |
| Underlying | ASTRAZENECA PLC |
| Issuer | 
UniCredit
|
| WKN | HR6WZC |
| ISIN | DE000HR6WZC5 |
| Date issued | 16/04/2021 |
| Strike | 6,705 p |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 1.69 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 6.84 € |
|---|---|
| Lowest since issue | 1.6 € |
| Spread | 0.01 € |
| Spread % | 0.16% |
Company Profile
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows:
- product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases);
- collaboration revenue (4.4%).
Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
Consensus: AstraZeneca PLC
Sell
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
153.7
USD
Average target price
170.1
USD
Spread / Average Target
+10.69%
- Stock Market
- Certificates
- Certificat
